DASSAULT SYSTÈMES IS IN TALKS TO BUY DRUG TRIAL SOFTWARE MAKER ARISGLOBAL FROM NORDIC CAPITAL FOR ABOUT $2 BLN - FT

Reuters · 1d ago

Please log in to view news